Thursday 16 October 2025
Home      All news      Contact us      RSS     
sciencedaily - 2 days ago

This experimental “super vaccine” stopped cancer cold in the lab

UMass Amherst researchers have developed a groundbreaking nanoparticle-based cancer vaccine that prevented melanoma, pancreatic, and triple-negative breast cancers in mice—with up to 88% remaining tumor-free. The vaccine triggers a multi-pathway immune response, producing powerful T-cell activation and long-term immune memory that stops both tumor growth and metastasis. By combining cancer-specific antigens with a lipid nanoparticle “super adjuvant,” it overcomes key challenges in cancer immunotherapy.


Latest News
Hashtags:   

experimental

 | 

“super

 | 

vaccine”

 | 

stopped

 | 

cancer

 | 

Sources